Abstract
The primary objective of the present research work was to develop nanoparticles incorporating (nanoparticulate) fast dissolving (orodispersible) film evincing enhanced solubility and bioavailability of nitrendipine (NIT). An antisolvent sonoprecipitation method was employed to produce the NIT nanosuspension (NS), which was optimized using the 32 optimal response surface design and then the optimized one was evaluated for various parameters (Gandhi et al., AAPS PharmSciTech 22 (1):1–15, 2021). The NIT nanoparticulate orodispersible film (N-ODF) was prepared utilizing the nanosuspension by the solvent casting method using the Vijay film-forming instrument. The N-ODF was optimized by the 23 full factorial design and was evaluated for several parameters. The optimized NS depicted a particle size of 505.74 ± 15.48 nm with a polydispersity index (PDI) of 0.083 ± 0.006 (Fig. 1b). The NIT nanoparticles showed a striking increment in saturation solubility (26.14 times), when compared with plain NIT (2). The developed NIT N-ODF exhibited thickness (0.148 ± 0.008 mm), folding endurance (280.33 ± 5.51 times), surface pH (6.86 ± 0.05), tensile strength (8.25 ± 0.13 kg/cm2), % elongation (63.5 ± 1.97%), and disintegration time (24.60 ± 1.31 s) to be within the standard intended limit. The in vitro dissolution study unveiled 100.28 ± 2.64% and 100.68 ± 2.50% of NIT release from lyophilized nanocrystals (in 8 min) and N-ODF (in 3.5 min), respectively, whereas the conventional NIT tablet took 30 min to release 99.94 ± 1.57% of NIT (Gandhi et al., AAPS PharmSciTech 22 (1):1–15, 2021). The in vivo pharmacokinetic study in rabbits inferred the achievement of significantly (p < 0.05) higher bioavailability of NIT on release from N-ODF in comparison to the conventional NIT tablet. Thus, the generation of N-ODF can be considered as a propitious move toward improving the efficacy of NIT to treat hypertension and angina pectoris.
Similar content being viewed by others
Data Availability
Applicable
References
Keck CM, Müller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur J Pharm Biopharm. 2006;62:3–16. https://doi.org/10.1016/j.ejpb.2005.05.009.
Gandhi NV, Deokate UA, Sachidanand SA. Development of nanonized nitrendipine and its transformation into nanoparticulate oral fast dissolving drug delivery system. AAPS PharmSciTech. 2021;22(3):1–15. https://doi.org/10.1208/s12249-021-01963-6.
Desai PP, Date AA, Patravale VB. Overcoming poor oral bioavailability using nanoparticle formulations-opportunities and limitations. Drug Discov Today Technol. 2012;9(2):e87–95. https://doi.org/10.1016/j.ddtec.2011.12.001.
Sharma M, Sharma R, Jain DK. Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs. Scientifica. 2016;2016:1–11. https://doi.org/10.1155/2016/8525679.
Majeed A, Raza SN, Khan NA. Hydrotrophy: novel solubility enhancement technique: a review. Int J Pharm Sci Res. 2019;10(3):1025–36. https://doi.org/10.13040/IJPSR.0975-8232.
Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharmaceutics. 2012;2012:1–10. https://doi.org/10.5402/2012/195727.
Sunder S, Nair R. Methods of nanonization of drugs for enhancing their dissolution. Eur J Advanc Engineer Techno. 2016;3(8):101–10.
Junyaprasert VB, Morakul B. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian J Pharm Sci. 2015;10(1):13–23. https://doi.org/10.1016/j.ajps.2014.08.005.
Pardeike J, Strohmeier DM, Schrödl N, Voura C, Gruber M. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. Int J Pharm. 2011;420(1):93–100. https://doi.org/10.1016/j.ijpharm.2011.08.033.
Tripathi KD. Essentials of Medical. Pharmacology. 2003:494–6.
Quan P, Xia D, Piao H, Shi K, Jia Y, Cui F. Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation. AAPS PharmSciTech. 2011;12(4):1136–43. https://doi.org/10.1208/s12249-011-9682-2.
Xia D, Quan P, Piao H, Sun S, Yin Y, Cui F. Preparation of stable nitrendipine nanosuspensions using the precipitation – ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci. 2010;40(4):325–34. https://doi.org/10.1016/j.ejps.2010.04.006.
Reddy LH, Ghosh B. Fast-dissolving-drug-delivery-systems: a review of the literature. Indian J Pharm Sci. 2002:31–336.
Chaudhary H, Gauri S, Rathee P, Kumar V. Development and optimization of fast dissolving oro-dispersible films of granisetron HCl using Box–Behnken statistical design. Bull Fac Pharm Cairo Univ. 2013;51:193–201. https://doi.org/10.1016/j.bfopcu.2013.05.002.
Karki S, Kim H, Jeong Na S, Shin D, Jo K, Lee J. Thin films as an emerging platform for drug delivery. Asian J Pharm Sci. 2016;11:559–74.
Irfan M, Rabel S, Bukhtar Q, Qadir MI, Jabeen F, Khan A. Orally disintegrating films: a modern expansion in drug delivery system. Saudi Pharma J. 2015;24:1–10. https://doi.org/10.1016/j.jsps.2015.02.024.
Steiner D, Finke JH, Kwade A. Efficient production of nanoparticle-loaded orodispersible films by process integration in a stirred media mill. Int J Pharm. 2016;511:804–13. https://doi.org/10.1016/j.ijpharm.2016.07.058.
Bajaj A, Rao M, Pardeshi A, Sali D. Nanocrystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan. AAPS PharmSciTech. 2012;13(4):1331–40. https://doi.org/10.1208/s12249-012-9860-x.
Jermain SV, Brough C, Williams RO. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery-an update. Int J Pharm. 2018;535:379–92. https://doi.org/10.1016/j.ijpharm.2017.10.051.
Junghanns JUA, Müller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine. 2008;3(3):295–309. https://doi.org/10.2147/ijn.s595.
Shen B, Shen C, Yuan X, Bai J, Yuan Q, Xu H. Development and characterization of an orodispersible film containing drug nanoparticles. Eur J Pharm Biopharm. 2013;85:1348–56. https://doi.org/10.1016/j.ejpb.2013.09.019.
Gurdale MS, Lade MS, Payghan SA, D'souza JI. Fast dissolving HPMC E5 based oral film for rapid absorption of metoprolol tartrate. Eur J Pharm Med Res. 2014;1(1):75–91.
Lai F, Franceschini I, Corrias F, Sala MC, Cilurzo F, Sinicoa C, et al. Maltodextrin fast dissolving films for quercetin nanocrystal delivery: a feasibility study. Carbohydr Polym. 2015;121:217–23. https://doi.org/10.1016/j.carbpol.2014.11.070.
Sharma R, Kamboj S, Singh G, Rana V. Development of aprepitant loaded orally disintegrating films for enhanced pharmacokinetic performance. Financ Res Lett. 2016;84:55–69. https://doi.org/10.1016/j.ejps.2016.01.006.
Jelvehgari M, Montazam SH, Soltani S, Mohammadi R, Azar K. Fast dissolving oral thin film drug delivery systems consist of ergotamine tartrate and caffeine anhydrous. Pharm Sci. 2015;21(2):102–10. https://doi.org/10.15171/PS.2015.24.
Tran TT, Tran KA, Tran PH. Modulation of particle size and molecular interactions by sonoprecipitation method for enhancing dissolution rate of poorly water-soluble drug. Ultrason-Sonochem. 2015;24:256–63. https://doi.org/10.1016/j.ultsonch.2014.11.020.
Mishra B, Sahoo J, Dixit PK. Fabrication of cinnarizine nanosuspensions by ultrasonication technique: a systematic study of formulation parameters on particle size and in-vitro dissolution. Biopharm J. 2015;1(1):12–21. https://doi.org/10.22159/ijap.2018v10i2.23075.
Pimparade MB, Maurya AS, Bae J, Morott JT. Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology. Eur J Pharm Biopharm. 2017;119:81–90. https://doi.org/10.1016/j.ejpb.2017.06.004.
Bonsu MA, Ofori-kwakye K, Kipo SL, Boakye-gyasi ME, Fosu M. Development of oral dissolvable films of diclofenac sodium for osteoarthritis using albizia and khaya gums as hydrophilic film formers. J Drug Deliv. 2016;2016:1–11. https://doi.org/10.1155/2016/6459280.
Patil P, Shrivastava SK. Formulation, evaluation and optimization of fast dissolving oral film of selective antihypertensive drug. World J Pharm Pharm Sci. 2014;3(8):996–1060.
Pawar SV, Junagade MS. Formulation and evaluation of mouth dissolving film of risperidone. Int J PharmTech Res. 2015;8(6):218–30.
Patel R, Shah D. Nanoparticles loaded sublingual film as an effective treatment of chemotherapy induced nausea and vomiting. Int J PharmTech Res. 2015;8(10):77–87.
Mahboob MBH, Riaz T, Jamshaid M, Bashir I, Zulfiqar S. Oral films: a comprehensive review. Int Curr Pharmaceu J. 2016;5(12):111–7 http://www.icpjonline.com/documents/Vol5Issue12/03.pdf.
Singh CK, Tiwari V, Shankar R, Mishra CP, Jain S, Jaiswal S. A short review on oral fast dissolving film containing cefpodoxime proxetil nanoparticle. World J Pharm Pharm Sci. 2016;5(1):1549–77.
Bharti K, Mittal P, Mishra B. Formulation and characterization of fast dissolving oral films containing buspirone hydrochloride nanoparticles using design of experiment. J Drug Deliv Sci and Tech. 2019;49:420–32. https://doi.org/10.1016/j.jddst.2018.12.013.
Chonkar AD, Rao JV, Managuli RS, Mutalik S, Dengale S, Jain P, et al. Development of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation. Eur J Pharm Biopharm. 2016;103:179–91. https://doi.org/10.1016/j.ejpb.2016.04.001.
Reddy PS, Murthy KVR. Formulation and evaluation of oral fast dissolving films of poorly soluble drug ezetimibe using transcutol Hp. Indian J of Pharma Edu and Res. 2018;52(3):398–407. https://doi.org/10.5530/ijper.52.3.46.
Venkateswarlu K. Preparation and evaluation of fast dissolving buccal thin films of bufotenin. J In Silico In Vitro Pharmacol. 2016;2(4):2–6.
ElMeshad AN, Hagrasy ASE. Characterization and optimization of orodispersible mosapride film formulations. AAPS PharmSciTech. 2011;12(4):1384–92. https://doi.org/10.1208/s12249-011-9713-z.
Elbary AA, Ali AA, Aboud HM. Enhanced dissolution of meloxicam from orodispersible tablets prepared by different methods. Bull Fac Pharmac. 2012;50(2):89–97. https://doi.org/10.1016/j.bfopcu.2012.07.001.
Chavan DU, Marques SM, Bhide PJ, Kumar L, Shirodkar RK. Rapidly dissolving Felodipine nanoparticle strips - formulation using design of experiment and characterization. J Drug Deliv Sci and Tech. 2020;60:1–15. https://doi.org/10.1016/j.jddst.2020.102053.
Vijayanand P, Patil JS, Reddy MV. Formulation and comparative pharmacokinetic evaluation of orodispersible tablets and films of nebivolol hydrochloride. J Pharm Inves. 2015;45:237–47.
El-setouhy DA, El-malak NSA. Formulation of a novel tianeptine sodium orodispersible film. AAPS PharmSciTech. 2010;11(3):1018–25. https://doi.org/10.1208/s12249-010-9464-2.
Papadimitriou S, Bikiaris D. Novel self-assembled core–shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release. J Control Release. 2009;138:177–84. https://doi.org/10.1016/j.jconrel.2009.05.013.
Chatwal GR, Anand SK. Instrumental methods of chemical analysis. New Delhi: Himalaya Publishing House. p. 2.60–71.
Chauhan A, Chauhan P. Powder XRD technique and its applications in science and technology. J Anal Bioanal Tech. 2014;5(5):1–5. https://doi.org/10.4172/2155-9872.1000212.
Bala R, Pawar P, Khanna S, Arora S. Orally dissolving strips: a new approach to oral drug delivery system. Int J Pharm Investig. 2013;3(2):67–76. https://doi.org/10.4103/2230-973X.114897.
Winarti L, Ameliana L, Nurahmanto D. Formula optimization of orally disintegrating tablet containing meloxicam nanoparticles. Indonesian J Pharm. 2017;28(1):53–64. https://doi.org/10.14499/indonesianjpharm28iss1pp53.
Desai PM, Liew CV, Heng PWS. Review of disintegrants and the disintegration phenomena. J Pharm Sci. 2016;105(9):2545–55. https://doi.org/10.1016/j.xphs.2015.12.019.
Acknowledgements
The authors would like to acknowledge Government College of Pharmacy, Aurangabad (M.S.), India; Wockhardt Ltd., Aurangabad (M.S.), India; and M.E.S.’s College of Pharmacy, Ahmednagar (M.S.), India, for the resource support provided.
Author information
Authors and Affiliations
Contributions
Neha Vishal Gandhi: conceptualization, methodology, investigation, software, formal analysis, data curation, writing—original draft, writing—review and editing, final approval of the version of the manuscript to be published, and agreement to be accountable for all aspects of the work. Uday Arvind Deokate: resources, writing—review and editing, final approval of the version of the manuscript to be published, and agreement to be accountable for all aspects of the work. Sachidanand Shankar Angadi: resources, writing—review and editing, final approval of the version of the manuscript to be published, and agreement to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
Applicable (IAEC Approval No. MES/COP/IAEC/04/2017-18)
Consent for Publication
Not applicable
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gandhi, N.V., Deokate, U.A. & Angadi, S.S. Formulation, Optimization and Evaluation of Nanoparticulate Oral Fast Dissolving Film Dosage Form of Nitrendipine. AAPS PharmSciTech 22, 218 (2021). https://doi.org/10.1208/s12249-021-02100-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-021-02100-z